The SPIRIT Group is an international collaboration of trialists, methodologists, journal editors, and ethicists from academia, industry, and funding agencies. The full group is responsible for the final content of the SPIRIT 2013 Statement. A subset of members wrote the SPIRIT 2013 Explanation & Elaboration paper.
SPIRIT Group members:
An-Wen Chan (Chair)
Women’s College Research Institute,
University of Toronto, Canada
Douglas Altman
Centre for Statistics in Medicine,
University of Oxford, United Kingdom
Jesse Berlin
Janssen Research & Development, Janssen Pharmaceutical Companies of Johnson & Johnson, USA
Kay Dickersin
Center for Clinical Trials,
Johns Hopkins Bloomberg School of Public Health, USA
Caroline Doré
Clinical Trials Unit,
Medical Research Council, United Kingdom
Geneviève Dubois-Flynn
Ethics office, Canadian Institutes of Health Research, Canada
Peter Gøtzsche
Nordic Cochrane Centre, Denmark
Trish Groves
BMJ, United Kingdom
Asbjørn Hróbjartsson
Nordic Cochrane Centre, Denmark
Karmela Krleža-Jerić
Department of Epidemiology and Community Medicine,
University of Ottawa, Canada
Andreas Laupacis
Keenan Research Centre, Li Ka Shing Knowledge Institute of St Michael’s Hospital, University of Toronto, Canada
Howard Mann
Division of Medical Ethics and Humanities,
University of Utah, USA
David Moher
Clinical Epidemiology Program,
Ottawa Hospital Research Institute, Canada
Wendy Parulekar
NCIC Clinical Trials Group,
Queen’s University, Canada
Drummond Rennie
The PR Lee Institute for Health Policy Studies,
University of California, USA
Frank Rockhold
GlaxoSmithKline, USA
Kenneth Schulz
Quantitative Sciences, FHI 360, USA
Harold Sox
The Dartmouth Institute for Health Policy and Clinical Practice,
The Geisel School of Medicine at Dartmouth, USA
William Summerskill
The Lancet, United Kingdom
Jennifer Tetzlaff
Ottawa Methods Centre,
Ottawa Hospital Research Institute, Canada
SPIRIT Staff
Ashley Lau
Women’s College Research Institute,
Toronto, Canada